15 Most Promising Long-Term Stocks According to Analysts
In this article, we will take a look at the 15 most promising long-term stocks according to analysts.
Eli Lilly & Co (LLY)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | GQG Partners Rajiv Jain | 1,647,718 | $602,801,153 | +4% | 1.62% |
| 2. | 1,371,700 | $501,822,728 | -45% | 0.11% | |
| 3. | 1,074,900 | $393,241,416 | -27% | 0.09% | |
| 4. | Adage Capital Management Phill Gross And Robert Atchinson | 981,642 | $359,123,909 | +10% | 0.85% |
| 5. | Duquesne Capital Stanley Druckenmiller | 737,725 | $269,889,314 | +53% | 13.35% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $304.19 | 656 | Director | 62,857 | 2022-08-12 | Filing | |
| $246.78 | 202 | Director | 15,436 | 2022-03-01 | Filing | |
| $182.99 | 546 | Director | 61,195 | 2021-04-30 | Filing | |
| $182.74 | 820 | Director | 60,649 | 2021-04-30 | Filing | |
| $108.84 | 1,000 | Officer | 22,043 | 2019-10-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $318.85 | 1,000 | Officer | 8,908 | 2023-03-10 | Filing | |
| $322.47 | 600 | Officer | 6,578 | 2023-02-27 | Filing | |
| $346.47 | 2,500 | Officer | 57,926 | 2023-02-13 | Filing | |
| $342.76 | 2,500 | Officer | 60,426 | 2023-02-10 | Filing | |
| $374.56 | 5,895 | Large Shareholder | 102,948,810 | 2022-12-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 102,948,810 | $37,662,792,650 | 100% | |
| 2. | 73,429,863 | $26,863,581,080 | 0.73% | |
| 3. | 65,081,481 | $23,809,408,940 | 0.74% | |
| 4. | 33,730,468 | $12,339,953,963 | 1.22% | |
| 5. | 33,715,087 | $12,334,327,428 | 0.72% |
News See All
15 Dividend Zombies and Kings With Longest Dividend Payouts
In this article, we will discuss 15 dividend zombies and dividend kings with the longest dividend payouts.
5 Mad Money Stock Picks This Week
Jim Cramer gave positive comments about Eli Lilly and Company (NYSE:LLY) in a Lightning Round of his program earlier this month.
Top 10 Drug Companies in USA and Their China Reliance
In this article, we will be taking a look at the top 10 drug companies in USA and their China reliance.
5 High Growth High Margin Stocks to Buy
In this article, we discuss 5 high growth high margin stocks to buy.
Eli Lilly and Company (NYSE:LLY) Q4 2022 Earnings Call Transcript
Operator: Ladies and gentlemen, thank you for standing by. And welcome to the Lilly Q4 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode.
12 Safe Stocks to Buy For Long-Term
In this article, we take a look at 12 safe stocks to buy for the long-term according to hedge funds.
Here's Why Eli Lilly and Company (LLY) Rose in Q4
Baron Funds, an investment management company, released its “Baron Health Care Fund” fourth quarter 2022 investor letter. A copy of the same can be downloaded here.
14 Best Dividend Stocks To Buy and Hold
Despite a slowing economy, investors remain confident in dividend growth to cushion their portfolios from financial blows in terms of eroding share prices.
5 Best Performing S&P 500 Stocks in the Last 5 Years
Thermo Fisher Scientific Inc. (NYSE:TMO) is a Massachusetts-based provider of life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and services worldwide.
Billionaire Hedge Funds
